Nicotine & the Gut

Nicotine and GERD: The Lower Esophageal Sphincter Connection

April 22, 202610 min readBy GLP1Gut Team
nicotineGERDacid refluxLESlower esophageal sphincter

📋TL;DR: Nicotine reduces lower esophageal sphincter (LES) pressure by inhibiting cholinergic tone in the smooth muscle of the LES. It also increases transient LES relaxations (TLESRs), the primary mechanism of reflux in most GERD patients. On top of that, nicotine reduces esophageal acid clearance by decreasing salivary bicarbonate secretion and esophageal peristalsis. This double hit (more acid getting up, less efficient clearing of it) is why GERD worsens with nicotine regardless of delivery method. Managing reflux while continuing nicotine use is possible but requires deliberate strategies.

What We Know

  • Nicotine reduces basal LES pressure in a dose-dependent manner (Kahrilas and Gupta, 1990).
  • Transient LES relaxations (TLESRs) increase during nicotine exposure, and TLESRs account for approximately 70% of reflux episodes in GERD patients.
  • Nicotine decreases salivary bicarbonate output, which reduces the esophagus's ability to neutralize refluxed acid (Kahrilas and Gupta, 1990).
  • Nicotine impairs secondary esophageal peristalsis, slowing the mechanical clearance of acid from the esophagus (Smit et al., 2001).
  • The effect occurs regardless of nicotine delivery method: cigarettes, pouches, patches, and gum all reduce LES pressure.
  • Smoking cessation improves GERD symptoms in the majority of patients within 1 to 3 months (Ness-Jensen et al., 2016).

What We Don't Know

  • Whether nicotine pouches produce a quantitatively different degree of LES relaxation compared to cigarettes (given the absence of carbon monoxide and other smoke components) is not established.
  • The threshold nicotine blood level at which LES pressure begins to drop meaningfully has not been precisely defined for oral nicotine products.
  • Whether intermittent, low-dose nicotine use (e.g., 3 mg pouches a few times per week) produces clinically significant reflux in people without pre-existing GERD is unclear.
  • Long-term data on esophageal outcomes (Barrett's esophagus, esophageal adenocarcinoma risk) specific to tobacco-free nicotine pouch users do not yet exist.

If you use nicotine in any form and have heartburn, the connection is not coincidental. Nicotine has a direct, well-documented effect on the valve that separates your esophagus from your stomach. That valve, the lower esophageal sphincter (LES), is a ring of smooth muscle that stays contracted to keep stomach acid where it belongs. Nicotine relaxes it. This has been known since at least the 1970s, and the mechanism has been studied extensively in manometry labs and clinical trials. What makes the nicotine-GERD relationship particularly frustrating is that nicotine does not just open the gate for acid. It also impairs the esophagus's ability to clean up once acid arrives. You get more reflux and less clearance, which is about the worst combination possible for esophageal health.

How does nicotine relax the lower esophageal sphincter?

The LES maintains its resting tone primarily through tonic cholinergic input. Acetylcholine, released from vagal nerve endings, keeps the smooth muscle contracted at a baseline pressure of roughly 15 to 30 mmHg. This pressure acts as a barrier against gastric contents moving upward. Nicotine disrupts this system through at least two mechanisms.

First, nicotine inhibits the release of acetylcholine at the LES by desensitizing presynaptic nicotinic receptors. A landmark study by Kahrilas and Gupta (1990) published in Gastroenterology measured LES pressure in healthy volunteers before and after nicotine administration (via smoking) and found a significant, dose-dependent reduction in basal LES pressure. Average pressure dropped by approximately 30% to 50% during active nicotine exposure. This effect was not mediated by systemic hemodynamic changes; it was a direct neuromuscular effect on LES tone.

Second, nicotine increases the frequency of transient lower esophageal sphincter relaxations (TLESRs). These are brief, complete relaxations of the LES that are not associated with swallowing. TLESRs are the single most common mechanism of gastroesophageal reflux, accounting for approximately 70% of reflux episodes in GERD patients (Mittal et al., 1995). TLESRs are mediated by a vago-vagal reflex arc involving gastric mechanoreceptors. Nicotine appears to lower the threshold for triggering this reflex, meaning the LES relaxes inappropriately more often.

â„šī¸Think of the LES as a door on a spring. Normally it stays shut with a certain force. Nicotine weakens the spring (reduced basal pressure) and also makes the door swing open more frequently on its own (increased TLESRs). Both effects increase the opportunities for acid to reach the esophagus.

Why does nicotine also impair esophageal acid clearance?

Here is the part that makes nicotine-related GERD particularly stubborn. When acid refluxes into the esophagus, your body has two main mechanisms for clearing it. The first is primary and secondary peristalsis, which are wave-like contractions that push the refluxed material back down into the stomach. The second is salivary neutralization: saliva contains bicarbonate, and when you swallow, that bicarbonate reaches the esophagus and neutralizes residual acid on the mucosal surface.

Nicotine impairs both. Smit et al. (2001) published a study in the American Journal of Gastroenterology showing that nicotine reduced the amplitude of secondary esophageal peristaltic contractions, meaning the mechanical clearing of acid was less efficient during nicotine exposure. Kahrilas and Gupta (1990) also demonstrated that nicotine decreased salivary bicarbonate output by approximately 30%, reducing the chemical neutralization capacity of swallowed saliva.

The net effect is that when nicotine allows more acid into the esophagus (via LES relaxation), the esophagus is simultaneously less capable of clearing that acid. This extends the duration of acid contact with the esophageal mucosa per reflux episode. Prolonged acid contact time is the key driver of esophageal mucosal damage, and it is what distinguishes occasional, harmless reflux (which everyone has) from pathological GERD that causes esophagitis, strictures, or Barrett's esophagus over time.

Does the nicotine delivery method matter for reflux?

This is a question pouch and vape users understandably want answered, and the short answer is: nicotine's LES effects occur regardless of delivery method, but the degree may vary. Cigarette smoke contains nicotine plus carbon monoxide, aldehydes, and other compounds that independently affect smooth muscle and mucosal integrity. So cigarettes may be worse for the esophagus than pure nicotine products. But pure nicotine alone is sufficient to reduce LES pressure.

A 2003 study by Pandolfino et al. in the American Journal of Gastroenterology measured LES pressure in healthy volunteers using nicotine patches (transdermal delivery) and found significant LES pressure reduction even without any smoke or oral exposure. The patch delivered steady-state nicotine with no combustion products, no swallowed saliva, and no local irritation, and it still weakened the sphincter. This confirms that nicotine itself, not the other components of cigarette smoke, is the primary driver of LES relaxation.

For nicotine pouches specifically, the buccal absorption route delivers nicotine somewhat more slowly than smoking but faster than a patch. No published manometry study has tested LES pressure changes specifically during pouch use as of early 2026. However, given that the mechanism is systemic (circulating nicotine acting on the LES neuromuscular junction), there is no pharmacological reason to expect pouches to spare the LES.

How much worse does nicotine make existing GERD?

The answer depends on your baseline GERD severity, but the epidemiological data is consistent. A large Norwegian population study (the HUNT study) by Ness-Jensen et al. (2016) published in the American Journal of Gastroenterology followed over 29,000 participants and found that tobacco cessation was associated with a 37% reduction in weekly GERD symptoms over 11 years of follow-up. The benefit was most pronounced in normal-weight individuals, suggesting that nicotine may be a relatively larger contributor to reflux in people who do not have obesity-related reflux drivers.

Another dataset comes from the Nurses' Health Study, which found that current smoking was associated with a 1.4-fold increased risk of frequent GERD symptoms (Zheng et al., 2007). Interestingly, former smokers had intermediate risk, suggesting that some of the esophageal effects of chronic nicotine exposure do not fully reverse immediately after cessation.

  • Mild GERD (occasional heartburn, no esophagitis): nicotine use consistently worsens symptom frequency and may convert occasional reflux into weekly symptoms.
  • Moderate GERD (esophagitis, regular symptoms): nicotine use reduces response to PPI therapy and increases breakthrough reflux episodes.
  • Severe GERD (Barrett's esophagus, stricture history): nicotine use increases esophageal acid exposure time, which is the key modifiable risk factor for disease progression.

Can you manage reflux while continuing to use nicotine?

The evidence-based advice is straightforward: stopping nicotine is the most effective single intervention for nicotine-related GERD. But the reality is that many people are not going to stop, and telling them to quit is not useful GI advice. For those who continue using nicotine, there are strategies that can reduce (but not eliminate) the reflux burden.

  • Time your nicotine use away from meals. The gastrocolic reflex already increases transient LES relaxations after eating. Adding nicotine on top of a meal amplifies this. If possible, wait at least 30 to 60 minutes after eating.
  • Avoid nicotine use within 3 hours of lying down. Reflux is gravity-dependent, and lying down with a nicotine-weakened LES is the highest-risk scenario.
  • Lower the dose if possible. LES pressure reduction is dose-dependent. A 3 mg pouch will relax the LES less than a 6 mg pouch.
  • Elevate the head of your bed 6 to 8 inches. This is one of the most effective mechanical anti-reflux interventions, and it works even with a weakened LES. Use a wedge pillow or bed risers, not extra pillows (which bend you at the waist and can worsen reflux).
  • Consider alginate-based products (Gaviscon Advance, the UK formulation). They form a physical raft over stomach contents that acts as a mechanical barrier independent of LES pressure.
  • If you are on a PPI, understand its limitations. PPIs reduce acid production but do not prevent reflux. You will still have weakly acidic and non-acid reflux episodes, which can cause symptoms even with full acid suppression.

PPIs (omeprazole, esomeprazole, lansoprazole, pantoprazole) are effective at reducing acid production and healing esophagitis, and they are appropriately prescribed for many GERD patients regardless of nicotine use. But they have a specific limitation in the context of nicotine: they do not fix the mechanical problem. The LES is still relaxed, and reflux events still occur. What changes is that the refluxate contains less acid.

For symptom control, this is often sufficient. Most heartburn and acid-related esophageal damage improve with PPIs. But weakly acidic reflux (which PPIs do not prevent) can still cause symptoms like regurgitation, chest discomfort, and chronic cough. A pH-impedance study by Vela et al. (2001) showed that PPIs reduced acid reflux episodes but did not reduce the total number of reflux events, many of which were weakly acidic and still symptomatic.

💡If you are on a PPI for GERD and still having breakthrough symptoms, and you use nicotine, the nicotine is likely a contributing factor. Reducing your nicotine dose or timing it away from meals and bedtime may improve symptom control more than increasing the PPI dose.

What helps with identifying your reflux triggers?

GERD symptoms vary significantly from person to person, and nicotine's contribution depends on dose, timing, other dietary triggers, body position, and anatomy. Tracking your reflux episodes alongside nicotine use, meals, and body position creates a personal pattern that generic advice cannot replicate. Tools like GLP1Gut can help you track symptom timing, nicotine use, and meals to identify which specific combinations are driving your worst reflux episodes.

This data is also useful if you end up seeing a gastroenterologist. A reflux diary with timestamps and nicotine use mapped alongside symptoms is more clinically useful than 'I have heartburn all the time.' It helps your doctor decide whether to adjust medications, order pH testing, or recommend specific lifestyle changes.

Does quitting nicotine improve GERD, and how quickly?

The HUNT study data suggests that the reflux benefit of cessation begins within the first year and continues to accumulate over time. LES pressure typically begins to recover within days to weeks of nicotine cessation, as the inhibitory effect on cholinergic tone resolves. Salivary bicarbonate production also normalizes relatively quickly.

However, if chronic nicotine-related reflux has already caused esophageal damage (esophagitis, Barrett's metaplasia), stopping nicotine removes one driver but does not reverse the existing tissue changes. Those patients typically still need acid suppression and endoscopic surveillance regardless of nicotine status. The point of quitting is to stop adding insult to an already injured esophagus, not to undo damage that has already occurred.

Can nicotine pouches cause Barrett's esophagus?

Barrett's esophagus develops from chronic acid exposure to the esophageal lining, and nicotine increases that exposure by weakening the LES and impairing acid clearance. No long-term studies specific to tobacco-free nicotine pouches and Barrett's risk exist yet. However, the mechanism (prolonged esophageal acid exposure) is the same regardless of how nicotine is delivered. If you have chronic GERD from any cause including nicotine use, Barrett's screening per your gastroenterologist's guidelines is reasonable.

Is nighttime reflux worse with nicotine?

Yes. When you lie flat, gravity no longer helps keep stomach contents below the LES. A nicotine-weakened LES combined with a supine position is a particularly high-risk combination. Avoiding nicotine for at least 2 to 3 hours before bed and elevating the head of your bed are the two most impactful interventions for nighttime reflux.

Key Takeaways

  1. 1Nicotine weakens the LES and increases the frequency of inappropriate sphincter relaxations, allowing more acid to reflux into the esophagus.
  2. 2At the same time, nicotine impairs the esophagus's ability to clear that acid, meaning each reflux episode does more damage.
  3. 3This is not a combustion-specific effect. Patches, pouches, gum, and vapes all deliver nicotine that affects LES function.
  4. 4If you have GERD and use nicotine, timing and dose management can reduce (but not eliminate) the impact.
  5. 5PPIs can mask nicotine-related reflux symptoms but do not address the mechanical problem at the LES.

Sources & References

  1. 1.Effect of Cigarette Smoking on the Lower Esophageal Sphincter - Kahrilas PJ, Gupta RR., Gastroenterology (1990)
  2. 2.Transient Lower Esophageal Sphincter Relaxation - Mittal RK, Holloway RH, Penagini R, et al., Gastroenterology (1995)
  3. 3.Effect of Nicotine on Oesophageal Motility and Gastro-Oesophageal Reflux - Smit CF, Copper MP, Schoots IG, et al., American Journal of Gastroenterology (2001)
  4. 4.Effect of Transdermal Nicotine on Lower Esophageal Sphincter Pressure - Pandolfino JE, Kahrilas PJ., American Journal of Gastroenterology (2003)
  5. 5.Tobacco Cessation and Weight Change in Relation to GERD: The HUNT Study - Ness-Jensen E, Lindam A, Lagergren J, Hveem K., American Journal of Gastroenterology (2016)
  6. 6.Tobacco Smoking, Gastroesophageal Reflux Disease, and Barrett's Esophagus - Zheng Z, Nordenstedt H, Pedersen NL, et al., Gastroenterology (2007)
  7. 7.Effects of Proton Pump Inhibitors on Weakly Acidic Reflux - Vela MF, Camacho-Lobato L, Srinivasan R, et al., Gut (2001)

Medical Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Always consult with a qualified healthcare professional before making changes to your diet, medications, or health regimen. GLP1Gut is a tracking tool, not a medical device.

Figure Out What's Actually Triggering You

An AI-powered meal and symptom tracker that connects what you eat to how you feel, built specifically for people on GLP-1 medications experiencing digestive side effects.